ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 75 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9 | -99.9% | 26,079 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -13.3% | 26,079 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -16.7% | 26,079 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -87.4% | 26,079 | -20.4% | 0.00% | – |
| Q2 2021 | $143,000 | -35.6% | 32,748 | +6.8% | 0.00% | – |
| Q1 2021 | $222,000 | +59.7% | 30,672 | -9.8% | 0.00% | – |
| Q3 2020 | $139,000 | -24.5% | 34,009 | +10.9% | 0.00% | – |
| Q2 2020 | $184,000 | +23.5% | 30,669 | +54.3% | 0.00% | – |
| Q1 2020 | $149,000 | – | 19,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |